Australia markets close in 2 hours 14 minutes

Silo Pharma, Inc. (SILO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1901+0.0051 (+2.76%)
At close: 3:59PM EDT

Silo Pharma, Inc.

560 Sylvan Avenue
Suite 3160
Englewood Cliffs, NJ 07632
United States
718 400 9031

Sector(s):Β Healthcare
Industry:Β Biotechnology
Full-time employees:Β 1

Key executives

NameTitlePayExercisedYear born
Mr. Eric WeisblumChairman, Pres, Chief Compliance Officer, CEO & CFO115kN/A1970
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research to address conditions, such as depression, post-traumatic stress disorder, Parkinson's, and other rare neurological disorders. It also offers NFID (No Found Identification) branded apparels, which include sweatshirts, hoodies, T-shirts, jackets, and hats. The company entered into a scientific research agreement with the University of Maryland. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Englewood Cliffs, New Jersey.

Corporate governance

Silo Pharma, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.